hypothyroidism: Abnormally low levels of thyroid hormone.
Hypothyroidism due to medicaments and other exogenous substances
DOID EFO Endpoint Browser PheWeb
E4_HYTHYSUBS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
376 |
4. Check minimum number of eventsNone |
376 |
5. Include endpointsNone |
376 |
6. Filter based on genotype QC (FinnGen only) |
376 |
Control definitions (FinnGen only)
- Control exclude
- E4_THYROID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E03
- Name in latin
- Hypothyreosis ex medicamentis sive aliis substantiis externis
Similar endpoints
↥List of similar endpoints to
Hypothyroidism due to medicaments and other exogenous substances
based on the number of shared cases.
Similar with more cases:
- Hypothyroidism (congenital or acquired)
- Hypothyreosis and Thyroxine purchase for inclusion criteria
- Disorders of the thyroid gland
- Used for control exclusion in common control thyroid runs
- Endocrine, nutritional and metabolic diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2311 | 1701 | 600 |
| Only index persons | 2080 | 1546 | 534 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.02 |
| Only index persons | 0.05 | 0.06 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 61.87 | 61.63 | 62.70 |
| Only index persons | 60.73 | 60.33 | 61.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 376 | 271 | 105 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.05 |
| Median age at first event (years) | 58.55 | 56.85 | 62.93 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 332
- Matched controls
- 3320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H03AA01
ATC
levothyroxine sodium; systemic
1347.5
323.0
314
42
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
+∞
323.0
317
*
H03BB01
ATC
carbimazole; oral
1221.4
158.2
142
*
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
504.4
135.2
126
*
104
Kela drug reimbursment
Thyroid insufficiency
559.9
118.6
111
*
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
+∞
111.9
101
*
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
+∞
92.0
84
*
E89.00
ICD-10 Finland
Postirradiation hypothyroidism
+∞
52.5
49
*
E03
ICD-10 Finland
Other hypothyroidism
119.7
39.7
42
*
E03.89
ICD-10 Finland
Other specified hypothyroidism
142.4
36.5
38
*
T86
ICPC
Hypothyroidism/myxoedema
65.6
26.4
30
5
E05.2
ICD-10 Finland
Thyrotoxicosis with toxic multinodular goitre
+∞
23.2
22
*
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
+∞
21.1
20
*
N05AN01
ATC
lithium; oral
15.6
20.9
34
24
C07AA05
ATC
propranolol; systemic
3.7
20.7
107
376
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
58.6
19.2
22
*
E05
ICD-10 Finland
Thyrotoxicosis [hyperthyroidism]
+∞
18.9
18
*
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
+∞
18.9
18
*
C01BD01
ATC
amiodarone; systemic
12.5
17.9
32
28
2443X
ICD-9 Finland
Acquired hypothyroidism, Other iatrogenic hypothyroidism
+∞
16.8
16
*
E89.01
ICD-10 Finland
Postsurgical hypothyroidism
+∞
15.7
15
*
BAA60
NOMESCO Finland
Total thyroidectomy
59.5
14.9
17
*
1502
Kela drug reimbursment
Cabozantinib
+∞
12.6
12
*
3012
Kela drug reimbursment
Cabozantinib
+∞
12.6
12
*
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.3
12.2
46
119
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
67.4
11.7
13
*
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
10.6
11.7
22
22
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
14.5
11.1
18
13
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
44.9
11.0
13
*
C07AB07
ATC
bisoprolol; oral
2.2
10.9
173
1095
E05.80
ICD-10 Finland
Subacute thyrotoxicosis
113.4
10.5
11
*
H06.2*E05.9
ICD-10 Finland
Dysthyroid exophthalmos
+∞
10.5
10
*
E05.1
ICD-10 Finland
Thyrotoxicosis with toxic single thyroid nodule
+∞
10.5
10
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
10.3
156
959
130
Kela drug reimbursment
Malignant tumour
3.7
10.0
44
131
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
20.8
9.9
14
7
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
9.6
86
410
E05.89
ICD-10 Finland
Other thyrotoxicosis
+∞
9.4
9
*
E89.09
ICD-10 Finland
Postprocedural hypothyroidism, other or several procedures
+∞
9.4
9
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
4.9
9.4
30
66
N05AX12
ATC
aripiprazole; systemic
6.6
8.9
22
35
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
51.3
8.7
10
*
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
13.2
8.4
14
11
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
9.8
8.4
16
17
L01XE26
ATC
[U] cabozantinib; oral
+∞
8.4
8
*
ZX120
NOMESCO Finland
Intravenous
3.1
8.1
45
159
N05AA02
ATC
levomepromazine; systemic
5.4
8.0
23
45
N05AF03
ATC
chlorprothixene; systemic
6.4
8.0
20
33
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.5
7.9
13
10
N05AH03
ATC
olanzapine; systemic
4.0
7.9
31
84
C03CA01
ATC
furosemide; systemic
2.1
7.7
97
539
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.5
7.6
62
278
N02BE01
ATC
paracetamol; systemic, rectal
2.4
7.6
291
2476
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
7.5
61
271
N03AG01
ATC
valproic acid; systemic, rectal
3.7
7.4
31
89
N05AH04
ATC
quetiapine; oral
2.5
7.3
61
277
L01EX07
ATC
cabozantinib; oral
+∞
7.3
7
*
E04.9
ICD-10 Finland
Nontoxic goitre, unspecified
16.2
7.3
11
7
C03DA01
ATC
spironolactone; oral
3.0
7.3
42
154
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
7.2
57
252
F31.8
ICD-10 Finland
Other bipolar affective disorders
10.3
7.1
13
13
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
7.2
7.1
16
23
H02AB06
ATC
prednisolone; systemic
1.9
7.0
156
1065
WX892
NOMESCO Finland
Monitored bed care
3.6
6.9
30
89
A03FA01
ATC
metoclopramide; systemic, rectal
2.1
6.8
84
456
N05BA04
ATC
oxazepam; oral
2.1
6.8
91
513
B01AB05
ATC
enoxaparin; parenteral
1.9
6.8
114
703
N05CF01
ATC
zopiclone; oral
1.9
6.7
117
730
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
10.3
6.6
12
12
B01AA03
ATC
warfarin; systemic
2.3
6.6
67
335
H02AB09
ATC
hydrocortisone; systemic
7.6
6.5
14
19
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.5
6.4
21
49
N05AX08
ATC
risperidone; systemic
3.2
6.3
31
102
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
18.4
6.3
9
5
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
+∞
6.3
6
*
N03AX09
ATC
lamotrigine; oral
4.1
6.1
22
56
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
153
102
24.61
185.20
6.1
1.5
pmol/l
4.3
4.4
0.60
140
90
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
97
42
30.78
139.07
2.8
1.2
iu/l
6.4
1.0
—
49
8
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
359
2308
13.29
38.57
13.7
2.6
pmol/l
15.7
14.4
15.94
344
2084
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
74
170
5.17
31.31
1.3
1.2
iu/ml
298.1
90.9
0.72
37
60
(3036481) Cortisol [Moles/volume] in Serum or Plasma
88
258
4.15
27.17
5.7
1.9
nmol/l
376.6
372.7
0.06
83
232
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
255
1494
3.20
24.86
10.3
5.9
mmol/l
1.2
1.2
0.04
210
1262
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
237
1353
3.03
23.81
8.9
5.1
mmol/l
1.2
1.2
0.13
221
1224
(3035637) Corticotropin [Mass/volume] in Plasma
28
32
9.37
22.70
2.8
1.3
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
115
476
3.04
20.23
5.2
2.6
mmol/l
0.8
0.8
0.06
110
453
(3018418) pH of Serum or Plasma
168
899
2.57
17.54
7.3
3.3
ph
7.4
7.4
0.45
43
179
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
359
2847
6.77
17.43
15.4
3.5
mu/l
2.5
1.9
2.21
345
2583
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
210
1273
2.47
16.43
2.8
2.3
nmol/l
75.5
77.8
0.61
193
1133
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
18
19
9.90
15.33
3.4
1.8
nmol/l
17.8
24.5
1.19
18
19
(3020779) Urea [Moles/volume] in Serum or Plasma
66
236
3.18
14.59
9.2
5.9
mmol/l
10.0
9.1
0.49
61
225
(3023368) Bacteria identified in Blood by Culture
145
776
2.41
14.56
5.6
4.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
64
228
3.18
14.22
3.9
3.2
ng/l
78.5
74.1
0.17
57
204
(3013650) Neutrophils [#/volume] in Blood by Automated count
255
1779
2.35
13.29
18.0
8.7
e9/l
3.9
4.1
0.78
224
1552
(42870588) Differential panel, method unspecified - Blood
171
1019
2.24
13.02
8.3
5.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
174
1045
2.24
12.98
5.5
3.2
mmol/l
2.3
2.4
0.42
155
921
(3024561) Albumin [Mass/volume] in Serum or Plasma
200
1293
2.17
12.16
6.4
4.1
g/l
34.6
35.6
1.49
186
1208
(40758558) Short blood count panel - Blood
139
779
2.24
12.11
12.1
6.7
—
—
—
0
0
(3044889) 12 lead EKG panel
289
2177
2.42
11.87
5.5
3.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
219
1483
2.14
11.62
9.5
5.5
%
27.0
28.2
0.83
202
1376
(3000991) Gas panel - Venous blood
58
219
2.95
11.57
9.0
7.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
216
1457
2.13
11.55
9.6
5.7
%
8.7
8.5
0.23
199
1357
(3021589) Normoblasts [#/volume] in Blood
207
1377
2.12
11.45
17.0
9.1
e9/l
0.0
0.0
0.27
174
1128
(3006504) Eosinophils/100 leukocytes in Blood
215
1451
2.13
11.45
9.5
5.4
%
2.9
2.8
0.35
196
1340
(3022096) Basophils/100 leukocytes in Blood
210
1405
2.12
11.44
9.6
5.4
%
0.7
0.7
0.08
193
1295
(3013826) Glucose [Moles/volume] in Serum or Plasma
247
1762
2.17
11.32
7.3
4.2
mmol/l
6.9
6.6
1.16
236
1646
(3018010) Neutrophils/100 leukocytes in Blood
215
1464
2.09
11.02
9.4
5.3
%
58.0
57.2
0.42
198
1367
(3019198) Lymphocytes [#/volume] in Blood
227
1579
2.10
10.97
9.7
5.3
e9/l
1.7
1.9
1.65
196
1396
(3006315) Basophils [#/volume] in Blood
224
1551
2.10
10.95
9.6
5.3
e9/l
0.0
0.0
0.34
190
1339
(3013115) Eosinophils [#/volume] in Blood
228
1601
2.08
10.59
9.8
5.8
e9/l
0.2
0.2
1.07
195
1417
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
160
990
2.07
10.49
4.7
3.0
u/l
26.7
30.8
1.92
150
947
(3001604) Monocytes [#/volume] in Blood
221
1540
2.06
10.41
9.7
5.3
e9/l
0.6
0.6
0.68
189
1330
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
305
2417
2.39
10.11
13.4
7.0
u/l
77.1
77.8
0.14
292
2267
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
63
4.36
10.06
3.1
2.3
u/ml
0.3
0.3
0.52
13
33
(3037467) Urinalysis macro (dipstick) panel - Urine
278
2132
2.17
9.83
5.9
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
63
270
2.60
9.83
5.1
3.4
mmol/l
1.6
2.0
0.59
51
216
(3004789) Transferrin [Mass/volume] in Serum or Plasma
85
422
2.31
9.62
2.8
2.0
g/l
2.4
2.4
0.10
80
385
(3031040) Bacteria [#/volume] in Urine by Automated count
268
2035
2.10
9.61
6.4
4.4
e6/l
545.2
2115.5
—
6
33
(3012544) pH of Venous blood
64
281
2.54
9.49
5.5
3.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
54
4.47
9.25
3.3
2.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
81
401
2.30
9.20
3.1
2.1
%
19.7
23.0
1.14
69
349
(3032080) INR in Blood by Coagulation assay
181
1222
1.93
8.84
12.1
8.6
inr
1.3
1.2
0.48
55
362
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
225
1637
1.93
8.72
10.4
5.7
umol/l
9.9
10.9
1.08
216
1559
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
151
963
1.95
8.71
4.9
2.3
u/l
58.9
55.4
0.72
143
899
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
140
871
1.97
8.68
3.6
3.0
ng/l
1948.2
1124.1
1.59
128
734
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
67
314
2.38
8.60
6.8
6.9
kpa
5.0
5.1
0.55
62
300
(3027801) Oxygen [Partial pressure] in Arterial blood
67
314
2.38
8.60
6.8
6.9
kpa
12.2
12.1
0.01
62
301
(3009466) Valproate [Moles/volume] in Serum or Plasma
19
41
4.83
8.44
5.1
4.2
umol/l
365.4
364.2
0.01
14
36
(3003396) Base excess in Arterial blood by calculation
67
317
2.36
8.41
6.8
6.9
mmol/l
0.3
1.5
1.76
51
252
(3026008) Bacteria identified in Urine by Culture
149
958
1.92
8.30
3.9
3.0
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
68
330
2.29
8.03
3.1
2.4
%
1.8
1.8
0.17
58
297
(3022948) Iron [Moles/volume] in Serum or Plasma
87
467
2.12
8.02
3.0
2.0
umol/l
11.9
13.2
1.02
82
423
(3021879) Hepatitis B virus core Ab [Presence] in Serum
46
186
2.68
8.02
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
69
339
2.27
7.91
2.0
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
68
333
2.27
7.86
1.9
1.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
163
1098
1.86
7.73
6.7
3.5
e6/l
111.4
76.0
0.42
111
755
(3030467) Casts [#/volume] in Urine by Automated count
134
851
1.89
7.62
5.1
2.8
e6/l
0.3
0.5
0.96
98
624
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
163
1102
1.85
7.61
5.4
2.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
209
1536
1.81
7.32
5.0
3.7
estimate
0.0
0.0
0.00
52
296
(3017143) Hepatitis C virus Ab [Presence] in Serum
61
295
2.27
7.24
1.6
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
190
1361
1.80
7.22
3.5
2.6
ug/l
133.9
111.8
0.68
172
1247
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
98
571
1.97
7.15
4.3
2.7
mmol/l
2.5
2.5
1.05
82
498
(3002582) Erythrocytes [#/volume] in Urine
141
930
1.83
7.00
5.6
2.9
e6/l
63.9
134.7
0.44
106
701
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
86
486
2.00
6.82
2.0
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
84
472
2.00
6.76
5.1
2.8
e6/l
3.4
2.4
0.38
48
232
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
171
1204
1.77
6.76
2.3
2.0
pmol/l
92.2
96.2
0.45
89
605
(3051611) Lipemic interference index of Serum or Plasma
14
28
5.15
6.75
3.5
2.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
95
564
1.92
6.50
5.4
3.4
ng/l
156.5
268.7
0.39
74
425
(3009261) Glucose [Presence] in Urine by Test strip
209
1570
1.75
6.49
5.1
3.7
estimate
0.0
0.0
0.50
52
285
(36304419) Bacteria [Presence] in Urine
127
827
1.81
6.48
5.3
2.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
206
1551
1.73
6.26
6.7
5.1
estimate
0.0
0.0
0.50
54
301
(3023520) Reticulocytes [#/volume] in Blood
51
243
2.27
6.25
3.3
2.4
e9/l
76.2
70.1
0.59
34
189
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
116
743
1.81
6.21
3.0
2.1
mg/l
2.8
3.2
0.85
100
637
(3021960) Folate [Moles/volume] in Serum or Plasma
115
736
1.81
6.17
1.6
1.5
nmol/l
20.8
21.9
0.40
103
622
(3026782) Osmolality of Urine
101
622
1.85
6.13
4.0
2.7
mosm/kgh2o
506.5
546.4
1.14
87
527
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
162
1147
1.72
6.11
5.3
3.7
ng/l
31.2
63.8
0.53
123
806
(3013707) Erythrocyte sedimentation rate by Westergren method
283
2342
1.84
6.08
5.1
3.9
mm/h
16.8
11.9
3.92
263
2155
(3002385) Erythrocyte distribution width [Ratio]
308
2623
1.96
5.99
33.1
15.9
%
13.9
13.7
1.64
303
2580
(3009508) Creatinine [Moles/volume] in Urine
134
905
1.75
5.95
5.0
3.0
mmol/l
7.1
7.3
0.15
117
750
(3022217) INR in Platelet poor plasma by Coagulation assay
68
371
2.02
5.90
25.4
21.9
inr
1.2
1.2
—
8
43
(3000850) Epithelial cells [#/volume] in Urine
102
638
1.82
5.86
3.7
2.3
e6/l
6.7
6.8
0.01
85
558
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
84
494
1.90
5.86
4.7
2.6
e6/l
1.2
1.2
0.03
48
255
(3052851) Hemolysis interference index of Serum or Plasma
24
81
3.10
5.80
3.2
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
55
281
2.12
5.68
2.5
2.2
u/l
28.4
29.3
0.15
47
233
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
16
42
3.93
5.59
1.2
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
348
3129
2.51
5.46
25.2
13.1
mg/l
21.2
22.8
0.51
307
2414
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
58
308
2.04
5.40
4.0
3.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
196
2.29
5.40
1.8
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
33
138
2.53
5.39
9.7
8.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
19
58
3.40
5.38
3.1
2.6
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
22
5.12
5.29
3.5
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
130
898
1.68
5.19
5.7
3.9
mg/mmol
14.7
8.9
0.63
87
548
(3007853) Bacteria identified in Skin by Aerobe culture
60
330
1.97
5.07
2.3
1.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
352
3202
2.56
5.00
30.0
15.1
mmol/l
4.0
4.0
1.38
347
3107
(40761536) Microorganisms panel - Urine sediment
51
269
2.04
4.83
5.7
3.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
27
108
2.62
4.83
8.9
3.3
g/l
0.2
0.2
0.09
21
39
(3012516) Albumin [Mass/volume] in Urine
122
848
1.65
4.68
4.7
3.1
mg/l
635.3
207.5
0.34
84
533
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
14
41
3.51
4.22
1.4
1.2
u/ml
113.0
118.2
—
5
9
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
15
47
3.28
4.10
1.4
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
184
1443
1.54
4.09
4.4
3.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
62
370
1.81
4.07
1.7
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
64
2.90
4.01
5.7
2.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
186
2.10
3.99
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
104
725
1.60
3.84
4.4
3.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
35
175
2.10
3.83
1.8
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
102
709
1.60
3.81
1.8
1.7
mg/l
1.9
1.2
0.82
73
566
(40767503) Oxygen content in Capillary blood by calculation
18
66
2.81
3.81
3.7
2.3
%
18.7
15.9
—
10
36
(3037522) Nuclear Ab [Titer] in Serum
63
389
1.74
3.69
1.4
1.3
titre
384.0
481.9
—
10
85
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
51
3.02
3.61
1.3
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
127
939
1.53
3.60
2.6
2.0
u/l
190.4
188.2
0.02
120
891
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
19
75
2.61
3.52
1.4
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
102
724
1.56
3.45
2.5
2.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
20
82
2.52
3.44
6.8
4.0
mg/l
1.7
1.6
0.19
20
74
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
19
76
2.58
3.43
1.3
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
37
3.32
3.37
1.3
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
355
3319
2.25
3.37
17.8
10.0
u/l
24.5
24.7
0.14
350
3211
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
43
3.10
3.28
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
116
856
1.51
3.27
1.8
1.6
mmol/l
1.5
1.3
0.89
98
720
(3019309) Folate [Moles/volume] in Red Blood Cells
80
543
1.60
3.26
2.1
1.7
nmol/l
1103.8
1258.2
0.97
66
399
(3020891) Body temperature
25
117
2.22
3.24
8.0
4.5
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
8
15
5.42
3.20
1.4
1.8
ug/l
72.0
55.1
—
8
15
(3042936) Bacteria identified in Isolate by Culture
63
407
1.66
3.12
2.2
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
348
3247
1.96
3.04
22.5
12.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
104
761
1.51
3.03
2.5
2.5
umol/l
339.6
7971.9
3.96
83
671
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
53
330
1.71
3.01
3.8
2.6
umol/l
5.3
6.7
0.66
45
288
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
40
3.07
3.00
1.4
1.4
nmol/l
0.6
0.6
0.09
12
35
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
40
3.07
3.00
1.8
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
16
63
2.61
2.99
2.1
4.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
16
64
2.57
2.91
1.3
1.7
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
21
96
2.26
2.89
2.0
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
151
1198
1.44
2.88
5.3
3.9
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
9
6.75
2.88
1.3
1.4
iu/ml
407.5
106.3
—
6
9
(3022806) Fractional oxyhemoglobin in Capillary blood
11
36
3.12
2.83
1.4
1.6
%
90.6
90.7
0.01
11
36
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
23
3.98
2.79
1.1
1.9
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
351
3299
1.96
2.77
31.1
15.6
umol/l
82.6
74.0
3.97
351
3299
(3019060) Gas panel - Arterial blood
33
183
1.88
2.75
4.9
5.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
14
54
2.65
2.73
3.0
2.7
e9/l
3.8
4.7
1.21
14
54
(3044640) Blood type and Crossmatch panel - Blood
125
966
1.44
2.72
2.8
2.3
—
—
—
0
0
(3017704) Immunofixation for Urine
6
10
6.08
2.71
1.0
2.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
80
2.31
2.65
2.7
2.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
194
0.35
2.62
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
38
2.95
2.60
1.3
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
56
2.56
2.56
3.1
3.2
%
58.2
58.4
0.02
14
56
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
19
88
2.22
2.55
3.1
4.0
—
3.1
—
0
8
(4035726)
46
289
1.67
2.54
1.6
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
33
3.09
2.54
1.4
1.5
nmol/l
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
10
33
3.09
2.54
1.1
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
75
531
1.52
2.52
1.3
1.3
u/ml
11.4
7.0
0.24
25
196
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
9
26
3.52
2.49
3.0
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
16
4.44
2.48
1.1
1.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
17
76
2.30
2.48
1.9
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
111
856
1.42
2.41
5.1
3.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
39
239
1.70
2.37
5.7
4.3
%
0.0
0.3
0.86
13
60
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
17
4.17
2.37
1.1
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
78
566
1.48
2.33
1.3
1.3
iu/ml
17.7
29.3
1.44
20
189
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
35
2.91
2.32
1.3
1.7
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
41
2.73
2.29
1.1
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
14
60
2.38
2.24
1.7
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
36
2.83
2.22
3.0
3.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
108
841
1.40
2.20
6.4
3.8
estimate
0.0
0.0
0.50
54
293
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
30
3.05
2.16
1.2
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
19
3.73
2.16
1.1
1.8
—
—
—
0
0
(3035880) pH of Pleural fluid
6
14
4.34
2.16
1.0
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
42
270
1.63
2.15
5.9
4.1
%
1.0
1.1
0.16
16
82
(3012441) Differential panel - Pleural fluid
9
31
2.95
2.08
1.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
85
642
1.42
2.05
1.8
1.7
pmol/l
455.5
13800053.3
0.50
71
529
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
15
4.05
2.04
1.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
70
2.19
2.01
1.4
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
11
4.59
1.94
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
59
2.25
1.86
1.2
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
20
108
1.90
1.85
1.2
1.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
324
3040
1.48
1.85
5.7
4.5
mmol/l
6.1
5.9
1.10
299
2776
(3001019) Free T4 and TSH panel - Serum or Plasma
24
138
1.79
1.84
2.8
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
53
2.31
1.82
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
315
2944
1.43
1.80
25.2
12.2
ml/min/173m2
76.5
80.5
2.50
284
2397
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
269
0.50
1.79
1.7
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
37
242
1.59
1.79
5.6
4.1
%
0.5
0.6
0.28
11
56
(3017446) Testosterone [Moles/volume] in Serum or Plasma
25
147
1.75
1.79
2.3
2.1
nmol/l
11.5
12.7
0.37
20
138
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
41
2.48
1.77
4.4
1.4
pg
31.1
32.2
—
10
41
(4306422)
9
36
2.54
1.75
1.2
1.1
—
—
—
0
0
(44790049)
9
36
2.54
1.75
1.4
1.4
—
—
—
0
0
(44806118)
9
36
2.54
1.75
1.4
1.4
—
—
—
0
0
(44790047)
9
36
2.54
1.75
1.4
1.4
—
—
—
0
0
(44790048)
9
36
2.54
1.75
1.4
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
24
2.95
1.73
1.1
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
13
3.88
1.72
1.0
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
42
2.42
1.69
1.2
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
38
255
1.55
1.66
6.2
4.2
%
0.0
0.2
2.66
13
76
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
25
2.83
1.65
2.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
56
408
1.44
1.65
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
49
2.28
1.65
1.2
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
87
684
1.35
1.64
1.3
1.2
u/ml
2.1
2.4
0.05
22
181
(40760892) CBC W Ordered Manual Differential panel - Blood
87
686
1.35
1.61
8.4
4.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
10
43
2.36
1.61
1.5
1.1
u/ml
2.2
1.5
—
5
11
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
17
92
1.89
1.58
1.4
1.6
iu/ml
0.0
0.2
—
7
20
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
92
1.89
1.58
1.2
1.4
g/l
1.3
1.2
0.82
17
87
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
308
2885
1.37
1.58
6.9
5.6
mmol/mol
42.0
39.7
2.76
292
2698
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
177
1.63
1.57
5.4
4.4
mmol/l
2.4
2.0
0.24
19
134
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
71
2.01
1.56
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
71
2.01
1.56
1.4
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
251
1.53
1.55
5.3
2.6
ml/min/173m2
55.8
64.9
1.19
21
100
(3009343) pH of Capillary blood
29
186
1.61
1.54
5.4
4.4
ph
7.4
7.4
—
8
30
(3025941) Bacteria identified in Stool by Culture
27
170
1.63
1.54
1.2
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
27
2.62
1.52
2.3
2.5
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
27
2.62
1.52
1.4
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
18
101
1.82
1.51
2.1
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
58
2.10
1.51
4.8
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
45
2.26
1.47
1.1
1.2
u/l
14.1
13.7
—
10
39
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
331
3148
1.43
1.45
5.7
4.9
mmol/l
2.7
2.8
0.97
307
2902
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
16
3.15
1.44
1.6
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
22
2.75
1.44
2.3
1.8
%
11.9
11.7
—
6
22
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
226
2043
1.27
1.44
3.5
3.0
u/l
52.3
44.1
0.74
213
1915
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
46
2.21
1.41
1.1
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
60
456
1.38
1.41
2.2
1.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
82
1.86
1.37
3.4
1.9
u/l
119.0
690.7
—
7
28
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
17
2.97
1.36
2.4
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
269
0.58
1.35
1.2
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
14
76
1.87
1.31
1.1
1.3
—
—
—
0
0
(4062490)
6
24
2.52
1.31
1.7
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
18
2.80
1.29
2.0
3.3
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
35
2.31
1.27
1.5
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
117
1.66
1.20
4.6
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
73
586
1.30
1.20
1.5
1.5
g/l
2.1
2.4
1.00
41
351
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
38
2.13
1.19
2.1
1.9
ug/l
15.2
17.9
—
8
38
(3004588) Protein electrophoresis panel - Serum or Plasma
30
208
1.48
1.17
3.5
2.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
20
2.52
1.15
1.0
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
299
2827
1.28
1.15
27.8
14.0
%
38.6
39.3
0.67
209
2046
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
119
1.63
1.14
1.8
1.6
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
81
665
1.28
1.13
5.7
4.1
kg/l
1.0
1.0
—
8
86
(3026389) Candida sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
3.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
59
1.89
1.08
1.0
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
59
1.89
1.08
1.0
1.2
—
—
—
0
0
(3013512) EKG study
105
894
1.24
1.08
3.9
3.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
13
75
1.76
1.04
1.5
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
22
2.29
1.03
1.2
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
323
3095
1.31
1.03
5.2
4.3
mmol/l
4.6
4.7
2.04
303
2879
(3000492) Spirometry study
38
284
1.38
1.01
1.6
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
7
35
2.02
1.00
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
124
1.56
0.99
2.2
1.8
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
23
2.19
0.98
1.0
1.0
u/ml
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
96
818
1.23
0.98
1.6
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
312
2983
1.27
0.97
4.5
3.8
mmol/l
1.4
1.2
2.34
291
2737
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
31
0.00
0.97
0.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
9
51
1.78
0.95
2.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
44
341
1.33
0.94
2.6
1.8
%
1.5
1.5
0.11
35
299
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
27
2.24
0.94
1.8
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
120
1.53
0.87
1.3
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
111
0.53
0.84
1.5
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
113
0.52
0.84
1.2
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
12
73
1.67
0.82
1.2
1.2
—
74.3
—
0
7
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
208
1931
1.17
0.80
3.2
3.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
319
3079
1.24
0.76
5.1
4.3
mmol/l
1.4
1.5
3.07
296
2845
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
24
2.10
0.75
2.4
1.2
ug/l
1.4
2.9
—
5
19
(4024509)
5
24
2.10
0.75
1.8
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
24
2.10
0.75
1.0
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
38
1.86
0.74
3.9
4.5
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
7
38
1.86
0.74
1.1
1.1
—
15.9
—
0
8
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
39
1.81
0.73
1.7
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
39
1.81
0.73
2.6
2.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
60
1.68
0.72
2.4
2.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
40
1.76
0.71
1.3
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
57
1.59
0.71
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
26
1.94
0.71
1.8
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
58
1.57
0.70
1.1
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
41
1.72
0.70
1.4
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
23
170
1.38
0.69
2.4
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
5
27
1.86
0.68
2.4
1.7
e9/l
0.7
1.0
—
5
13
(3044941) Cell count panel - Synovial fluid
7
43
1.64
0.67
1.6
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
28
1.80
0.66
1.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
20
147
1.38
0.63
2.0
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
50
1.61
0.61
1.9
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
51
1.58
0.61
5.6
1.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
545
1.19
0.57
1.5
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
30
243
1.25
0.51
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
65
1.39
0.51
4.7
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
101
1.40
0.50
1.2
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
101
1.40
0.50
1.2
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
45
1.57
0.49
3.9
3.6
u/ml
27.3
84.0
—
7
45
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
45
1.57
0.49
1.9
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
46
1.53
0.48
1.9
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
46
1.53
0.48
1.9
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
10
68
1.48
0.47
1.8
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
48
1.47
0.47
1.1
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
77
1.44
0.46
1.2
1.5
ug/g
273.8
299.8
—
5
41
(42529406) Shigella sp [Presence] in Stool by Culture
14
103
1.37
0.46
1.2
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
130
1.32
0.44
5.7
5.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
33
1.52
0.41
2.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
32.6
—
0
16
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
34
1.48
0.40
1.4
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
67
1.35
0.38
1.1
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
44
386
1.16
0.36
2.1
2.3
ug/g
133.9
129.2
0.04
37
312
(1761868) Lipid panel - Serum or Plasma
105
1128
0.90
0.36
3.2
2.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
39
339
1.17
0.36
4.0
4.1
ug/l
2.9
10.0
2.89
32
280
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
6
41
1.47
0.36
1.2
1.1
mmol/l
6.9
7.1
—
6
26
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
38
330
1.17
0.35
1.4
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
42
1.44
0.35
1.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
42
1.44
0.35
1.2
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
136
1281
1.10
0.35
2.3
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
286
0.83
0.35
1.6
1.4
—
—
—
0
0
(1002224) Polysomnography panel
17
137
1.25
0.32
1.2
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
75
1.34
0.30
1.6
1.2
mmol/l
4.3
3.8
—
10
69
(3000494) Fungus identified in Specimen by Culture
43
383
1.14
0.30
1.5
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
241
1.17
0.30
5.0
3.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
375
0.87
0.29
3.9
4.3
%
32.3
32.9
0.09
22
247
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
9
73
1.24
0.25
1.6
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
9
77
1.17
0.24
6.4
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
74
691
1.09
0.24
3.6
5.1
ug/l
1.7
3.0
1.59
62
615
(3019225) pH of Specimen
31
276
1.13
0.23
4.6
3.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
18
153
1.19
0.23
3.2
4.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.8
—
2.2
—
0
12
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
48
1.25
0.20
6.3
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
4.9
—
216.4
—
0
14
(3028433) Virus identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
49
1.23
0.20
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
23
203
1.14
0.19
4.0
2.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
51
1.18
0.19
1.2
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
81
1.24
0.19
1.1
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
37
339
1.10
0.18
1.4
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
19
215
0.88
0.17
3.1
2.6
e9/l
4.3
3.9
0.32
11
172
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
70
1.15
0.16
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
25
226
1.11
0.15
1.2
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
80
1.13
0.15
6.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
80
1.13
0.15
6.4
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
81
1.11
0.15
6.4
1.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
86
0.81
0.14
2.7
3.3
u/ml
23.6
27.0
—
7
86
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
19
209
0.90
0.11
2.2
2.4
—
9.6
—
0
8
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
188
0.90
0.11
1.3
1.3
—
27.7
—
0
10
(1761482) Bacteria [#/volume] in Urine by Culture
11
96
1.15
0.10
5.4
5.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
14
125
1.12
0.10
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(4094501)
10
88
1.14
0.08
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
68
1.03
0.08
1.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
81
0.86
0.07
8.3
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
103
0.87
0.06
1.4
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
27
283
0.95
0.05
2.5
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
100
1.10
0.05
1.2
1.9
—
—
—
0
0
(4010399)
21
222
0.94
0.05
2.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
39
403
0.96
0.04
2.3
3.2
ug/l
0.6
0.8
0.97
23
264
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
160
0.93
0.04
1.1
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
129
0.93
0.03
1.2
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
23
220
1.05
0.03
2.2
1.6
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
112
1.07
0.03
1.8
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
51
520
0.98
0.02
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
37
363
1.02
0.01
10.7
7.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
56
553
1.01
0.01
3.0
4.5
%
24.3
20.9
0.72
16
277
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
166
0.96
0.00
1.3
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
256
0.97
0.00
2.3
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
117
1.03
0.00
1.5
2.0
—
—
—
0
0
(4034850)
11
105
1.05
0.00
13.5
9.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
11
115
0.96
0.00
1.5
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
96
1.04
0.00
1.5
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
465
0.99
0.00
1.1
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
84
0.95
0.00
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
8
0.00
0.00
0.0
1.1
—
2.9
—
0
8
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
7.2
—
0
5
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
51
0.98
0.00
4.0
2.8
mmol/l
4.0
4.0
—
5
51
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.7
—
0
5
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
8
85
0.94
0.00
1.8
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
82
0.98
0.00
1.1
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
113.0
—
0
9
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
6
67
0.89
0.00
1.2
1.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
8
89
0.90
0.00
1.0
1.1
—
2.4
—
0
13
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44806071)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
51
0.98
0.00
4.0
2.8
mmol/l
106.2
106.0
—
5
51
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
51
0.98
0.00
4.0
2.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_HYTHYSUBS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYTHYSUBS | 1.474 [1.22, 1.77] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.062 |
During the follow-up period (1.1.1998 — 31.12.2019), 266 out of 1295 females with E4_HYTHYSUBS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_HYTHYSUBS | 1.706 [1.2, 2.43] | 0.003 |
| Birth year | 0.991 [0.98, 1.0] | 0.059 |
During the follow-up period (1.1.1998 — 31.12.2019), 125 out of 448 males with E4_HYTHYSUBS died.
Mortality risk
Mortality risk for people of age
years, who have E4_HYTHYSUBS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.126% | 0.325% |
| 5 | 0.678% | 1.992% |
| 10 | 1.908% | 5.386% |
| 15 | 3.619% | 10.489% |
| 20 | 6.044% | 17.534% |
Relationships between endpoints
↥Index endpoint: E4_HYTHYSUBS – Hypothyroidism due to medicaments and other exogenous substances
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data